bit.bio
Developer of a cell coding technology designed for a new generation of cell therapies by democratizing access to consist
Biotechnology
📍 Cambridge, United Kingdom
Founded 2016
Current Valuation
$739M
as of 2021-Q4
PRIVATE
Developer of a cell coding technology designed for a new generation of cell therapies by democratizing access to consistent and functional human cells.
Company Profile
HQ
Cambridge, United Kingdom
Last Round
Series B — $188M (Dec 2021)
Fundraising Status
Series B · $188M · 4y 6mo ago
privateTotal raised $250M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series B | $188M | Dec 2021 | — | $739M |
Health CareBiotechnologyCommercial
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2021-Q4. Refreshed quarterly.